Literature DB >> 16506357

Life-threatening bradyarrhythmia after massive azithromycin overdose.

John A Tilelli1, Kathleen M Smith, Robert Pettignano.   

Abstract

9-month-old infant was inadvertently administered azithromycin 50 mg/kg, taken from floor stock, instead of the prescribed ceftriaxone. Shortly thereafter, she became unresponsive and pulseless. The initial heart rhythm observed when cardiopulmonary resuscitation was started was a widecomplex bradycardia, with a prolonged rate-corrected QT interval and complete heart block. The baby was resuscitated with epinephrine and atropine, but she suffered severe anoxic encephalopathy. Torsade de pointes and QT-interval prolongation have been reported after administration of macrolide antibiotics, including azithromycin, both intravenously and orally. This has occurred especially in the context of coadministered drugs that inhibit the cytochrome P450 (CYP) 3A4 isoenzyme, such as ketoconazole and astemizole. However, bradycardia with complete heart block has not, to our knowledge, been reported specifically with intravenous administration of azithromycin alone, either with therapeutic doses or overdose. Clinicians should be alerted about the potential of azithromycin to cause life-threatening bradycardia, and pharmacy systems should be implemented to ensure special care in the safe administration of this drug, especially when dispensed from a point-of-care source.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506357     DOI: 10.1592/phco.2006.26.1.147

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  9 in total

1.  Azithromycin Causes a Novel Proarrhythmic Syndrome.

Authors:  Zhenjiang Yang; Joseph K Prinsen; Kevin R Bersell; Wangzhen Shen; Liudmila Yermalitskaya; Tatiana Sidorova; Paula B Luis; Lynn Hall; Wei Zhang; Liping Du; Ginger Milne; Patrick Tucker; Alfred L George; Courtney M Campbell; Robert A Pickett; Christian M Shaffer; Nagesh Chopra; Tao Yang; Bjorn C Knollmann; Dan M Roden; Katherine T Murray
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-04

2.  Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.

Authors:  Rose M Viscardi; Ahmed A Othman; Hazem E Hassan; Natalie D Eddington; Elias Abebe; Michael L Terrin; David A Kaufman; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

3.  Evaluation of azithromycin induced cardiotoxicity in rats.

Authors:  Ozlem Atli; Sinem Ilgin; Hakan Altuntas; Dilek Burukoglu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Chiara Zuliani; Arno Muller; Herman Goossens; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

5.  Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.

Authors:  Jules C Hancox; Mehrul Hasnain; W Victor R Vieweg; Ericka L Breden Crouse; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2013-10

6.  Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Bradycardia and Hypothermia Complicating Azithromycin Treatment.

Authors:  Kerri Benn; Sam Salman; Madhu Page-Sharp; Timothy M E Davis; Jim P Buttery
Journal:  Am J Case Rep       Date:  2017-08-11

8.  Safety of azithromycin in pediatrics: a systematic review and meta-analysis.

Authors:  Linan Zeng; Peipei Xu; Imti Choonara; Zhenyan Bo; Xiangchen Pan; Wenyan Li; Xiaofeng Ni; Tao Xiong; Can Chen; Leshan Huang; Shamim Ahmad Qazi; Dezhi Mu; Lingli Zhang
Journal:  Eur J Clin Pharmacol       Date:  2020-07-17       Impact factor: 2.953

Review 9.  Use and safety of azithromycin in neonates: a systematic review.

Authors:  Coral Smith; Oluwaseun Egunsola; Imti Choonara; Sailesh Kotecha; Evelyne Jacqz-Aigrain; Helen Sammons
Journal:  BMJ Open       Date:  2015-12-09       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.